Bartosz Kubisa

ORCID: 0000-0003-1226-7020
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Transplantation: Methods and Outcomes
  • Organ Transplantation Techniques and Outcomes
  • Lung Cancer Diagnosis and Treatment
  • Pleural and Pulmonary Diseases
  • Medical Imaging and Pathology Studies
  • Renal Transplantation Outcomes and Treatments
  • Esophageal and GI Pathology
  • Mechanical Circulatory Support Devices
  • Lung Cancer Treatments and Mutations
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Polyomavirus and related diseases
  • Organ and Tissue Transplantation Research
  • Esophageal Cancer Research and Treatment
  • Tracheal and airway disorders
  • Lung Cancer Research Studies
  • Pneumothorax, Barotrauma, Emphysema
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cancer Diagnosis and Treatment
  • Intestinal Malrotation and Obstruction Disorders
  • Congenital Heart Disease Studies
  • Trace Elements in Health
  • RNA modifications and cancer
  • Microbial infections and disease research
  • Cancer Immunotherapy and Biomarkers
  • MXene and MAX Phase Materials

Pomeranian Medical University
2015-2024

University of Szczecin
2014-2024

Medical University of Warsaw
2024

Royal College of Surgeons in Ireland
2023

Heliodor Swiecicki Clinical Hospital
2023

Poznan University of Medical Sciences
2023

University College Cork
2023

Fusion Academy
2020

Fusion (United States)
2020

Clinical Research Consortium
2020

Michael A. Gillette Shankha Satpathy Song Cao Saravana M. Dhanasekaran Suhas Vasaikar and 95 more Karsten Krug Francesca Petralia Yize Li Wen-Wei Liang Boris Reva Azra Krek Jiayi Ji Xiaoyu Song Wenke Liu Runyu Hong Lijun Yao Lili M. Blumenberg Sara R. Savage Michael C. Wendl Bo Wen Kai Li Lauren C. Tang Melanie A. MacMullan Shayan C. Avanessian M. Harry Kane Chelsea J. Newton MacIntosh Cornwell Ramani Kothadia Weiping Ma Seungyeul Yoo Rahul Mannan Pankaj Vats Chandan Kumar‐Sinha Emily Kawaler Tatiana Omelchenko Antonio Colaprico Yifat Geffen Yosef E. Maruvka Felipe da Veiga Leprevost Maciej Wiznerowicz Zeynep H. Gümüş Rajwanth Veluswamy Galen Hostetter David I. Heiman Matthew A. Wyczalkowski Tara Hiltke Mehdi Mesri Christopher R. Kinsinger Emily S. Boja Gilbert S. Omenn Arul M. Chinnaiyan Henry Rodriguez Qing Kay Li Scott D. Jewell Mathangi Thiagarajan Gad Getz Bing Zhang David Fenyö Kelly V. Ruggles Marcin Cieślik Ana I. Robles Karl R. Clauser Ramaswamy Govindan Pei Wang Alexey I. Nesvizhskii Li Ding D.R. Mani Steven A. Carr Alex Webster Alicia Francis Alyssa Charamut Amanda G. Paulovich Amy M. Perou Andrew K. Godwin Andrii Karnuta Annette Marrero-Oliveras Barbara Hindenach Barbara L. Pruetz Bartosz Kubisa Brian J. Druker Chet Birger Corbin D. Jones Dana R. Valley Daniel C. Rohrer Daniel Cui Zhou Daniel W. Chan David Chesla David Clark Dmitry Rykunov Donghui Tan Elena V. Ponomareva Elizabeth R. Duffy Eric Burks Eric E. Schadt Erik J. Bergstrom Eugene S. Fedorov Ewa P. Malc George D. Wilson Haiquan Chen Halina Krzystek

To explore the biology of lung adenocarcinoma (LUAD) and identify new therapeutic opportunities, we performed comprehensive proteogenomic characterization 110 tumors 101 matched normal adjacent tissues (NATs) incorporating genomics, epigenomics, deep-scale proteomics, phosphoproteomics, acetylproteomics. Multi-omics clustering revealed four subgroups defined by key driver mutations, country, gender. Proteomic phosphoproteomic data illuminated downstream copy number aberrations, somatic...

10.1016/j.cell.2020.06.013 article EN cc-by-nc-nd Cell 2020-07-01
Shankha Satpathy Karsten Krug Pierre M. Jean Beltran Sara R. Savage Francesca Petralia and 95 more Chandan Kumar‐Sinha Yongchao Dou Boris Reva M. Harry Kane Shayan C. Avanessian Suhas Vasaikar Azra Krek Jonathan T. Lei Eric J. Jaehnig Tatiana Omelchenko Yifat Geffen Erik J. Bergstrom Vasileios Stathias Karen E. Christianson David I. Heiman Marcin Cieślik Song Cao Xiaoyu Song Jiayi Ji Wenke Liu Kai Li Bo Wen Yize Li Zeynep H. Gümüş Myvizhi Esai Selvan Rama Soundararajan Tanvi H. Visal Maria Gabriela Raso Edwin R. Parra Özgün Babur Pankaj Vats Shankara Anand Tobias Schraink MacIntosh Cornwell Fernanda Martins Rodrigues Houxiang Zhu Chia-Kuei Mo Yuping Zhang Felipe da Veiga Leprevost Chen Huang Arul M. Chinnaiyan Matthew A. Wyczalkowski Gilbert S. Omenn Chelsea J. Newton Stephan C. Schürer Kelly V. Ruggles David Fenyö Scott D. Jewell Mathangi Thiagarajan Mehdi Mesri Henry Rodriguez Sendurai A. Mani Namrata D. Udeshi Gad Getz James Suh Qing Kay Li Galen Hostetter Paul K. Paik Saravana M. Dhanasekaran Ramaswamy Govindan Li Ding Ana I. Robles Karl R. Clauser Alexey I. Nesvizhskii Pei Wang Steven A. Carr Bing Zhang D.R. Mani Michael A. Gillette Alexander L. Green Alfredo Molinolo Alicia Francis Amanda G. Paulovich Andrii Karnuta Antonio Colaprico Barbara Hindenach Barbara L. Pruetz Bartosz Kubisa Brian J. Druker Carissa A. Huynh Charles A. Goldthwaite Chet Birger Christopher R. Kinsinger Corbin D. Jones Dan Rohrer Dana R. Valley Daniel W. Chan David Chesla Donna E. Hansel Elena V. Ponomareva Elizabeth R. Duffy Eric Burks Eric E. Schadt Eugene S. Fedorov Eunkyung An

Lung squamous cell carcinoma (LSCC) remains a leading cause of cancer death with few therapeutic options. We characterized the proteogenomic landscape LSCC, providing deeper exposition LSCC biology potential implications. identify NSD3 as an alternative driver in FGFR1-amplified tumors and low-p63 overexpressing target survivin. SOX2 is considered undruggable, but our analyses provide rationale for exploring chromatin modifiers such LSD1 EZH2 to SOX2-overexpressing tumors. Our data support...

10.1016/j.cell.2021.07.016 article EN cc-by-nc-nd Cell 2021-08-01

IntroductionAdjuvant platinum-based chemotherapy is standard treatment for surgically resected stage II to IIIA NSCLC, but the relapse rate high. The preferentially expressed antigen of melanoma (PRAME) tumor in two-thirds NSCLC and offers an attractive target antigen-specific immunization. A phase I dose escalation study assessed safety immunogenicity a PRAME immunotherapeutic consisting recombinant plus proprietary immunostimulant AS15 patients with (NCT01159964).MethodsPatients...

10.1016/j.jtho.2016.08.120 article EN cc-by-nc-nd Journal of Thoracic Oncology 2016-10-10

We assessed whether blood cadmium levels were associated with incident lung cancer and could be used in the context of a screening program for early-stage cancer. measured among 205 patients matched controls. Cases controls sex, age smoking history (total pack-years, years since cessation former smokers). The odds ratio those highest quartile level (versus lowest) was four-fold (OR = 4.41, 95 % CI:2.01–9.67, p < 0.01). association present smokers 16.8, CI:3.96−71.2, 0.01), but not current...

10.1016/j.jtemb.2020.126682 article EN cc-by-nc-nd Journal of Trace Elements in Medicine and Biology 2020-11-12

Chronic obstructive pulmonary disease, cystic fibrosis and usual interstitial pneumonia are three most common indications for lung transplantation (LuTx) in Poland. As a result of irreversible destruction parenchyma extended respiratory insufficiency that appear afterwards, it is crucial to estimate the reserve gas exchange each before during surgery. Altering conditions require adaptation circulatory system as well. In some cases use extracorporeal life support appears be necessary undergo...

10.1186/s13019-021-01719-0 article EN cc-by Journal of Cardiothoracic Surgery 2021-11-27

Transplanted lungs suffer worse outcomes than other organ transplants with many developing chronic lung allograft dysfunction (CLAD), diagnosed by physiologic changes. Histology of transbronchial biopsies (TBB) yields little insight, and the molecular basis CLAD is not defined. We hypothesized that gene expression in TBBs would reveal nature distinguish from changes due simply to time posttransplant. Whole-genome mRNA profiling was performed microarrays 498 prospectively collected INTERLUNG...

10.1111/ajt.16895 article EN cc-by-nc-nd American Journal of Transplantation 2021-12-01
Alessandro Brunelli Herbert Decaluwé Michel Gonzalez Dominique Gossot René Horsleben Petersen and 95 more Henrik Aamodt Apostolos C. Agrafiotis Clemens Aigner А. Л. Акопов Ihsan Alloubi Antonio Álvarez Phillip Antippa Mara B. Antonoff Beatrice Aramini Florian Augustin Leah M. Backhus Sion Barnard Hasan Fevzi Batırel Alessandro Bertani Pietro Bertoglio Luca Bertolaccini Ciprian Bolca Edward Caruana Stephen D. Cassivi Marco Chiappetta Niccolò Daddi Wei Dai E. de Loos Marc de Perrot Georges Decker Lieven Depypere Frank C. Detterbeck Duilio Divisi Xavier Benoît D’Journo Joel Dunning Hussein Elkhayat Pierre‐Emmanuel Falcoz Pier Luigi Filosso Christophoros N. Foroulis Marta Fuentes József Furák Markus Furrer Shilpa Gandhi David Gómez de Antonio María Teresa Gómez-Hernández Michael R. Gooseman Francesco Guerrera Shadi Hamouri Henrik Jessen Hansen David Healy Jeroen Hendriks Lin Huang Niek Hugen Marcelo F. Jiménez Yekta Altemur Karamustafaoğlu Peter Kestenholz Puja Gaur Athanassios Kleontas Aris Koryllos Bartosz Kubisa Gunda Leschber Joseph Lula Lukadi Luca Luzzi Alessandro Wasum Mariani Gilbert Massard Nóra Mayer Anna Minasyan Fabrizio Minervini John D. Mitchell Lucia Morelli Bernhard Moser Natalia Motaş Igor Motus Mario Nosotti Nuria M. Novoa Isabelle Opitz A. Palleschi Kostas Papagiannopoulos Michael Peer Hans Pilegaard Cezary Piwkowski Eugenio Pompeo Elena Prisciandaro Federico Raveglia Herman Rijna María Rodríguez Lorenzo Rosso Enrico Ruffini Igor Saftić Alberto Sandri Paolo Scanagatta Marco Scarci Didier Schneiter Hermien Schreurs Ghada Shahin Piergiorgio Solli Georgios C. Sotiropoulos Willem H. Steup Zalán Szántó Miguel Lia Tedde

10.1093/ejcts/ezae015 article EN other-oa European Journal of Cardio-Thoracic Surgery 2024-02-01

Abstract Lung cancer is the leading cause of cancer-related death worldwide. Exposure to environmental and occupational carcinogens an important lung cancer. One these substances chromium, which found ubiquitously across planet. The International Agency for Research on Cancer has classified chromium(VI) as a human carcinogen. aim this study was assess whether serum chromium levels, well DNA variants in selected genes involved carcinogenesis, xenobiotic-metabolism, oxidative stress could be...

10.1007/s12011-020-02240-6 article EN cc-by Biological Trace Element Research 2020-07-09

Pulmonary resections after pneumonectomy due to metastases or metachronous non-small cell lung cancer (NSCLC) are rare because of the high potential risk second procedure and uncertain long-term results. On basis our series (largest in Europe) we tried assess survival patients treated stage IV NSCLC.Retrospective analysis was carried out on 18 at department by followed additional resection years 1981-2002 (15 males 3 females, 44-69 years, mean 57). Eleven pneumonectomies were performed right...

10.1016/j.ejcts.2008.05.023 article EN European Journal of Cardio-Thoracic Surgery 2008-06-26

In lung transplantation, antibody-mediated rejection (AMR) diagnosed by ISHLT criteria is uncommon compared to other organs, and previous studies failed find molecular AMR (ABMR) in biopsies. However, understanding of ABMR has changed with the recognition that kidney transplants often DSA-negative associated NK cell transcripts. We therefore searched for a similar ABMR-like state transbronchial biopsies (TBBs) using gene expression microarray results from INTERLUNG study (#NCT02812290)....

10.1016/j.ajt.2023.06.003 article EN cc-by American Journal of Transplantation 2023-06-08

Lung transplantation is an acceptable treatment option for various end-stage pulmonary diseases, but long-term survival currently lags behind that after of other solid organs. We hypothesized gene transfer to grafts before may be a useful method deliver antioxidant and/or anti-inflammatory genes modulate these processes. For this purpose, we assessed the efficiency and effects on lung function synthetic polycation, linear polyethylenimine (PEI), airway instillation lungs Fischer rats....

10.1006/mthe.2001.0413 article EN cc-by-nc-nd Molecular Therapy 2001-07-01

Background/Aim: The analysis of prognostic factors is important to identify determinants disease-free survival (DFS) and overall (OS) in resected non-small-cell lung cancer (NSCLC). Patients Methods: We examined baseline characteristics associated with DFS OS among 757 patients resected, histologically proven, MAGE-A3-positive Stage IB-IIIA NSCLC assigned placebo the MAGRIT study (NCT00480025). explored that could predict using Cox regression models. Results: multivariate showed lower nodal...

10.21873/anticanres.13255 article EN Anticancer Research 2019-03-01

Abstract: Tracheostomy is a routinely done procedure in the setting of intensive care unit (ICU) patients requiring prolonged mechanical ventilation. There are two ways making tracheostomy: an open surgical tracheostomy and percutaneous dilatational tracheostomy. Percutaneous associated with fewer complications than In this study, we would like to compare both techniques performing ICU present possible complications, methods diagnosing treating minimizing their risk. Keywords: tracheostomy,...

10.2147/tcrm.s135553 article EN cc-by-nc Therapeutics and Clinical Risk Management 2017-08-01

Background: Primary graft dysfunction (PGD) is a form of acute lung injury (ALI) that occurs within 72 h after transplantation (LuTx) and the most common early complication procedure. PGD diagnosed graded based on ratio partial pressure arterial oxygen to fraction inspired chest X-ray results. grade 3 increases recipient mortality chance chronic allograft (CLAD). Method: The aim this retrospective study was identify new risk factors. inclusion criteria were met by 59 patients, who all...

10.3390/clinpract14040127 article EN cc-by Clinics and Practice 2024-08-15

The effect of 1,25-dihydroxycholecalciferol (calcitriol, vitamin D3) with a low-calcium diet on the acute lung allograft rejection in rat unilateral left transplantation model was evaluated. Three groups were studied (n = 5, male Brown-Norway to Fischer F344, 235 ± 15 g body weight): calcitriol and diet, normal diet. Calcitriol (4 μg/kg/day) injected intraperitoneally for 5 days, starting from day transplantation. In addition, two non-transplantation compared: 3, Brown-Norway) measure level...

10.1093/ejcts/ezs150 article EN European Journal of Cardio-Thoracic Surgery 2012-04-11
Coming Soon ...